2020
|
Invention
|
E. coli (etec) and cholera. The present invention relates to a novel vaccine formulation for Ente... |
2019
|
Invention
|
Novel shigella vaccine formulation and process to prepare thereof. The present invention relates ... |
|
Invention
|
Process to prepare thereof. Neisseriameningitidis meningitidis serogroup A, C, Y and W capsular p... |
|
Invention
|
Purification of neisseria meningitidis polysaccharides. The present invention relates to a novel ... |
|
Invention
|
Novel meningococcal vaccine composition and process thereof. Neisseria meningitidisNeisseria meni... |
|
Invention
|
Media composition for production of bacterial polysaccharides. Neisseria meningitidisN. meningiti... |
2018
|
Invention
|
Purification of bacterial polysaccharides.
The present invention relates to rapid purification o... |
|
Invention
|
Purification of bacterial polysaccharides. The present invention relates to rapid purification of... |
|
Invention
|
Production of bacterial polysaccharides.
The present invention particularly relates to culture m... |
|
Invention
|
Novel multivalent polysaccharide-protein conjugate vaccine composition and formulation thereof.
... |
|
Invention
|
Novel multivalent polysaccharide – protein conjugate vaccine composition and formulation thereof.... |
|
Invention
|
A rapid high yielding purification process for neisseria meningitidis serogroup x capsular polysa... |
|
Invention
|
Production of bacterial polysaccharides. The present invention particularly relates to culture me... |
|
Invention
|
A novel synthetic neisseria meningitidis serogroup a oligomer and process for synthesizing thereo... |
2017
|
Invention
|
Novel polysaccharide-protein conjugates and process to obtain thereof. The present invention rela... |
2016
|
Invention
|
Process for production of purified recombinant cholera toxin b (rctb) and formulation thereon. Vi... |
|
Invention
|
A novel process for production of purified recombinant cholera toxin b (rctb) and formu lation th... |
2015
|
Invention
|
Process for formulating acid stabilized oral bacterial vaccine. A process for formulating an oral... |
|
Invention
|
Process of conjugation and novel synthetic oligosaccharide-protein conjugates obtained thereof. C... |
|
Invention
|
Novel neisseria meningitidis serogroup y oligomer and process for synthesizing thereof. The prese... |
|
Invention
|
An improved process of conjugation and novel synthetic oligosaccharide- protein conjugates obtain... |
|
Invention
|
Thermostable spray dried rotavirus vaccine formulation and process thereof. The present invention... |
|
Invention
|
An improved thermostable spray dried rotavirus vaccine formulation and process thereof. The prese... |
|
Invention
|
A thermostable freeze dried rotavirus vaccine formulation and process to prepare thereof. The pre... |
|
Invention
|
Neisseria meningitis serogroup x and process of preparing them. Neisseria meningitidis serogroup ... |
|
Invention
|
Downstream process for purifying polysaccharides. N. meningitidis infection. |
|
Invention
|
Novel synthetic oligomers of neisseria meningitis serogroup x and process of preparing them. The ... |
|
Invention
|
A novel downstream process for purifying polysaccharides. The present invention relates to a nove... |
|
Invention
|
Novel oligomers and process of preparing thereof. The present invention relates to synthesis of n... |
2014
|
Invention
|
Polysaccharide-protein conjugates with enhanced immunogenicity and rapid high yielding process of... |
2010
|
Invention
|
E. coli (etec) diarrhea. Vibrio cholerae O1 cells for use in such vaccines, DNA-constructs for th... |
|
Invention
|
Vaccine against cholera and enterotoxigenic e. coli (etec) diarrhea. A vaccine against cholera an... |